Edina, MN, United States of America

Clark C Chen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Clark C Chen

Introduction

Clark C Chen is an accomplished inventor based in Edina, MN (US). He has made significant contributions to the field of cancer treatment through his innovative patents. With a focus on utilizing electromagnetic signals for tumor treatment, Chen's work aims to improve the efficacy of cancer therapies.

Latest Patents

Chen holds 2 patents related to devices and methods for the treatment of tumors using electromagnetic signals. His latest patents detail systems and methods for treating cancerous tumors, including glioblastoma multiforme (GBM), through electrotherapy techniques such as deep brain stimulation (DBS). These patents describe how configurations can be generated based on a patient's tumor characteristics. The selected configurations may include electrode arrangements or settings for an electrical source connected to the electrodes. The targeted configurations aim to inhibit cell growth processes, such as mitosis, immune suppression, or DNA replication, ultimately leading to the death of cancerous cells.

Career Highlights

Chen is affiliated with the University of Minnesota, where he continues to advance his research in cancer treatment technologies. His work has garnered attention for its potential to revolutionize how tumors are treated, particularly in challenging cases like GBM.

Collaborations

One of Chen's notable collaborators is Gregory F Molnar, with whom he has worked on various projects related to his patents and research initiatives.

Conclusion

Clark C Chen's innovative approach to cancer treatment through electromagnetic signals represents a significant advancement in medical technology. His contributions have the potential to improve outcomes for patients battling tumors, showcasing the importance of continued research and innovation in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…